Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 609 clinical trials
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

), for the treatment of subjects with newly diagnosed advanced ovarian cancer who have undergone optimal debulking.

cancer chemotherapy
cancer of the ovary
serous cystadenocarcinoma
neutrophil count
oregovomab
  • 25 views
  • 09 Apr, 2021
  • 51 locations
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

ovarian cancer incidence.

oophorectomy
cancer of the ovary
fallopian tube
BRCA2
rad51c
  • 0 views
  • 25 Jan, 2021
  • 2 locations
A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)

This trial will study tisotumab vedotin to find out what its side effects are and to see if it works for platinum-resistant ovarian cancer (PROC). It will test different doses of tisotumab

cancer chemotherapy
cancer of the ovary
line of therapy
primary peritoneal carcinoma
peritoneal cancer
  • 97 views
  • 17 Apr, 2021
  • 46 locations
A Study of Fluzoparib Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy

with Stage III or IV ovarian cancer. Patients must have completed first-line platinum based regimen with Complete Response (CR) or Partial Response (PR). The study contains a Safety Lead-in Phase in

cancer chemotherapy
cancer of the ovary
fallopian tube
apatinib
platinum-based chemotherapy
  • 0 views
  • 25 Jan, 2021
  • 1 location
Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma

The current study aims at answering the scientific question, whether exfoliated cells from STICs get transported into the uterine cavity via the fallopian tube, and whether it is possible to detect those cells in the lavage fluid from the uterine cavity and proximal fallopian tubes. To address this question, the …

BRCA1/2
cancer of the ovary
fallopian tube
serous cystadenocarcinoma
carcinoma
  • 95 views
  • 10 Apr, 2021
  • 17 locations
Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer

Atezolizumab in this study is expected to have a positive benefit-risk profile for the treatment of patients with platinum-sensitive relapse of ovarian cancer. Of interest, atezolizumab is being

  • 7 views
  • 26 Jan, 2021
  • 88 locations
Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

This is a phase III, randomized, partially blinded, multicenter trial to evaluate the efficacy and safety of atezolizumab plus bevacizumab and chemotherapy compared to placebo plus bevacizumab and chemotherapy in patients with recurrent ovarian-, fallopian tube, or primary peritoneal cancer with 1st or 2nd relapse within 6 months after platinum …

  • 65 views
  • 24 Jan, 2021
  • 107 locations
A Study of ZN-c3 in Patients With Platinum-Resistant Ovarian Cancer

This is a Phase 1b open-label, multicenter study, evaluating the safety, tolerability, preliminary clinical activity, pharmacokinetics (PK), and pharmacodynamics of ZN-c3 in combination with other drugs.

  • 0 views
  • 29 Mar, 2021
  • 24 locations
Carboplatin and Paclitaxel With or Without Cediranib in Treating Women With Relapsed Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer

RATIONALE: Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cediranib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth …

combination chemotherapy
paclitaxel
tumor cells
ovarian epithelial cancer
peritoneal cancer
  • 41 views
  • 07 Nov, 2020
  • 6 locations
Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers

The hypothesis of this 3 year, prospective randomized multicenter efficacy trial is that a structured life-style intervention program with exercise training and mediterranean diet is effective regarding increased adherence to a mediterranean diet, reduction of body mass index, and increase of physical fitness.

  • 83 views
  • 26 Jan, 2021
  • 20 locations